Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan C Fagan

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Pharmacotherapy|October 22, 2011
Stroke is one of the most common and undertreated diseases in the world, and ischemic stroke makes up more than 85% of all strokes. IntroductionSusan C Fagan
Nature Reviews. Neurology|July 20, 2010
Stroke: Measuring disease-free life after thrombolysisSusan C Fagan
Reviews in Neurological Diseases|April 23, 2010
Old drugs, new tricks: update on stroke therapeuticsSusan C Fagan
Reviews in Neurological Diseases|April 23, 2010
Drug repurposing for drug development in strokeSusan C Fagan
Pharmacotherapy|June 26, 2010
Drug repurposing for drug development in strokeSusan C Fagan
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|May 6, 2008
Urgent need for secondary stroke prevention after transient ischemic attackSusan C Fagan
The American Journal of Geriatric Pharmacotherapy|May 17, 2011
Secondary prevention of stroke in the elderly: a review of the evidenceAhmed Alhusban, Susan C Fagan
Pharmacotherapy|June 26, 2010
Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocyclineDavid C Hess, Susan C Fagan
Reviews in Neurological Diseases|April 23, 2010
Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocyclineDavid C Hess, Susan C Fagan
Cardiovascular Drug Reviews|July 12, 2005
Oxidative stress and cardiovascular disease: antioxidants and unresolved issuesKamakshi Sachidanandam, Susan C Fagan, Adviye Ergul
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Pharmacotherapy|October 22, 2011
Stroke is one of the most common and undertreated diseases in the world, and ischemic stroke makes up more than 85% of all strokes. IntroductionSusan C Fagan
Nature Reviews. Neurology|July 20, 2010
Stroke: Measuring disease-free life after thrombolysisSusan C Fagan
Reviews in Neurological Diseases|April 23, 2010
Old drugs, new tricks: update on stroke therapeuticsSusan C Fagan
Reviews in Neurological Diseases|April 23, 2010
Drug repurposing for drug development in strokeSusan C Fagan
Pharmacotherapy|June 26, 2010
Drug repurposing for drug development in strokeSusan C Fagan
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|May 6, 2008
Urgent need for secondary stroke prevention after transient ischemic attackSusan C Fagan
The American Journal of Geriatric Pharmacotherapy|May 17, 2011
Secondary prevention of stroke in the elderly: a review of the evidenceAhmed Alhusban, Susan C Fagan
Pharmacotherapy|June 26, 2010
Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocyclineDavid C Hess, Susan C Fagan
Reviews in Neurological Diseases|April 23, 2010
Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocyclineDavid C Hess, Susan C Fagan
Cardiovascular Drug Reviews|July 12, 2005
Oxidative stress and cardiovascular disease: antioxidants and unresolved issuesKamakshi Sachidanandam, Susan C Fagan, Adviye Ergul
Pageof 14